Literature DB >> 23750169

Identification and distribution of nontuberculous mycobacteria from 2005 to 2011 in cheonan, Korea.

Jae Kyung Kim1, Insoo Rheem.   

Abstract

BACKGROUND: Nontuberculous mycobacteria (NTM) are considered opportunistic pathogens, and several species of NTM are associated with human diseases that typically involve the pulmonary, skin/soft tissue, or lymphatic systems; such infection may also cause disseminated diseases. Recent studies have reported increasing rates of NTM-induced disease worldwide.
METHODS: Respiratory samples are being analyzed for acid-fast bacilli (AFB) culture and NTM identification at Dankook University Hospital in Cheonan, Korea, from September 2005 to September 2011. Identification is performed by using polymerase chain reaction-restriction fragment length polymorphism analysis targeting a novel region of the rpoB gene.
RESULTS: A total of 25,133 specimens were received for AFB culture, of which 1,014 (4.0%) were NTM-positive. A total of 267 samples from 186 patients were tested for NTM identifications, and 232 samples from 157 patients were positive for NTM species. Among the patients who tested positive for NTM, 65.6% were men and the average age was 63.3 years. Mycobacterium avium complex, the most commonly detected NTM pathogen, was found in 65.9% of the 232 samples. The annual average percentage of NTM isolates from AFB culture-positive specimens was 31.3%: the highest rate was seen in 2011 (44.3%), followed by 2009 (37.4%) and 2010 (37.2%). An upward trend in NTM incidence was found during the study period.
CONCLUSION: The prevalence of pulmonary NTM isolates continues to increase in Cheonan, suggesting that pulmonary NTM disease is becoming increasingly common.

Entities:  

Keywords:  Age Distribution; Mycobacterium avium Complex; Nontuberculous Mycobacteria

Year:  2013        PMID: 23750169      PMCID: PMC3672413          DOI: 10.4046/trd.2013.74.5.215

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


Introduction

Mycobacteria species other than those of the Mycobacterium tuberculosis complex (MTBC) are called nontuberculous mycobacteria (NTM) or "atypical" mycobacteria. NTM are environmental organisms found in soil and water throughout the world1,2. NTM are generally hardy, ubiquitous environmental bacteria that vary in geographic distribution and pulmonary pathogenicity. NTM can also cause disseminated disease3. Disseminated disease due to NTM is primarily associated with acquired immunodeficiency syndrome and other forms of severe immunosuppression4. However, the incidence of NTM disease in patients without human immunodeficiency virus infection is increasing5. Different NTM species have different antibiotic susceptibility patterns, and their resistance to anti-tuberculosis drugs is of particular importance. For these reasons, the accurate and early differential diagnosis of MTBC and NTM is required for optimal outcomes. Currently, the identification of clinical isolates of mycobacteria at the species level is primarily based on the characteristics of the cultured bacteria and the biochemical test results. These conventional tests can take several weeks to perform and cannot always precisely identify the species6. Furthermore, these testing procedures are complex and laborious, and they are usually impeded by the slow growth of mycobacteria in culture. There are numerous species of NTM, and recently developed molecular methods have enabled the recognition of many of these species7. In this study, NTM were identified using a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method, based on the rpoB gene, at the Korean Institute of Tuberculosis8,9. Mycobacterial identification at the species level is both of academic interest and of importance for gaining a better understanding of the organisms' epidemiology and pathogenesis. Geographic variability in the environmental exposure and prevalence of NTM disease is of global significance10. Given these clinical challenges, further knowledge of the epidemiology of NTM in Korea is needed. The purpose of this study was to identify NTM and investigate their distribution in clinical specimens isolated from a tertiary teaching hospital in Cheonan, Korea.

Materials and Methods

This study included the isolation of NTM species from all clinical specimens referred to Dankook University Hospital Laboratory in Cheonan, Korea, from September 2005 to September 2011 (Table 1). Patients for whom NTM identification tests were requested provided samples of sputum and bronchial washing fluid. For this study, we retrospectively analyzed the results of these samples. Data were analyzed and categorized according to gender, age, and year of analysis.
Table 1

Basic statistics of AFB culture and NTM identifications

*Positive rate of AFB culture: positive culture results/referred tests in specimens or patients. †Rate of NTM identification to AFB culture-positive results: positive NTM results/AFB culture-positive results in specimens or patients.

AFB: acid-fast bacilli; NTM: nontuberculous mycobacteria.

1. Culture

1) Sample pre-processing:

For respiratory samples, N-acetyl-L-cysteine (NALC)-NaOH solution (5% NaOH+ 0.5% NALC) was added to the sample to liquefy and decontaminate the mucous sputum. The solution was centrifuged at 3,000 ×g for 18 minutes at 4℃, and the supernatant was discarded. Phosphate buffered saline 1 mL was added after the sediment had been vortexed.

2) Mycobacterial culture:

The processed samples (0.2 mL) were used to inoculate 3% Ogawa medium (Eiken, Tokyo, Japan) and were cultured for 8 weeks in an incubator at 35-37℃ under 5-10% CO2. An interim report was provided at 4 weeks, if necessary. Samples (0.5 mL each) were used to inoculate MGIT medium (Becton Dickinson, Sparks, MD, USA) after mixing with PANTA/supplement according to the manufacturer's protocol. The tubes were then incubated for 6 weeks in the BACTEC MGIT 960 system (Becton Dickinson). If fluorescence was detected in the tube, the test was considered positive.

2. NTM identification

NTM identification was performed at the Korean Institute of Tuberculosis, where PCR-RFLP methods are used to target a novel region of the rpoB gene.

3. Statistical analysis

The statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA). The Cochran-Armitage test for trend was used to evaluate the tendency of isolating NTM from respiratory acid-fast bacilli (AFB)-culture specimens over the years studied.

Results

1. Characteristics of NTM-positive patients

A total of 25,133 specimens were received for AFB culture, of which 3,236 (12.9%) were AFB positive and 1,014 (4.0%) were NTM positive. A total of 267 samples from 186 patients were collected for NTM identification, and 232 samples from 157 patients were positive for NTM species (Table 1). Gender analysis showed that 66.7% of all patients were men, and that 65.6% of the NTM-positive patients were men. The average patient age was 63.3 years (range, 33.3-91.1 years). More than 50% of patients were aged 60-79 years (Figure 1).
Figure 1

Age group distribution of the positive specimens. Forty-four patients (28.0%) were aged 60-69 years, 37 patients (23.6%) were aged 70-79 years, and 34 patients (21.7%) were aged 50-59 years. M., Mycobacterium.

2. Distribution of NTM species

Mycobacterium avium complex (MAC), the most common NTM, was detected in 153 samples (65.9%): M. intracellulare was detected in 119 and M. avium in 34 samples. M. kansasii was the next most prevalent species (18 isolates, 7.8%), followed by M. abscessus complex (M. abscessus and M. massiliense; 15 isolates, 6.5%) and M. gordonae (12 isolates, 5.2%) (Table 2). The annual distributions of NTM species are detailed in Table 3.
Table 2

Distribution of species after nontuberculous mycobacteria (NTM) identification according to specimens and patients

*M. abscessus complex: M. abscessus and M. massiliense. †Other species: M. szulgai, M. chelonae, M. ulcerans, M. nonchromogenicum, M. peregrinum, and M. simiae.

Table 3

Annual incidence of nontuberculous mycobacteria (NTM) species

*M. abscessus complex: M. abscessus and M. massiliense. †Other species: M. szulgai, M. chelonae, M. ulcerans, M. nonchromogenicum, M. peregrinum, and M. simiae.

The overall proportion of NTM isolates from among the respiratory AFB-positive specimens was 31.3% (1,014/3,236); the highest rate was seen in 2011 (192/433, 44.3%), followed by 2009 (135/361, 37.4%) and 2010 (246/662, 37.2%). There was an upward trend in NTM proportion in respiratory specimens during the study period (Cochran-Armitage test for trend, p<0.001) (Figure 2).
Figure 2

Annual changes in the proportions of nontuberculous mycobacteria (NTM) vs. Mycobacterium tuberculosis complex (MTBC) isolates in respiratory specimens. The trend showed increasing rates, from 25.6% in 2005 to 44.3% in 2011.

Discussion

NTM are ubiquitous in the environment, and are found in water, soil, and air, as well as in animal-derived materials. Currently, more than 140 species of NTM are known11, and 50 species have been identified as opportunistic pathogens in humans12. NTM isolation and disease prevalence seems to be increasing worldwide13-15, and in Korea16-18. We assessed NTM species distribution and epidemiologic trends from isolates during 2005-2011 in the Cheonan area of Korea. In the study by Lee et al.19, the gender ratio of patients with NTM disease was close to 1 (male:female ratio of 1.07:1). The study by Choi et al.20, on the other hand, found a male:female ratio of 2.56:1. Our results (male:female ratio of 1.91:1) lead us to conclude that NTM is not strongly associated with gender, but rather depends more on region and timing. In our study, the average age was 63.3 years: 28.0% of patients were aged 60-69 years, and 23.6% were aged 70-79 years. The average patient age in other studies of NTM disease were as follows: 48.7 years in the study by Baek et al.21 performed in 1998-1999, 53 years in the study by Lee et al.19 performed in 1999, 58 years in the study by Choi et al.20 performed in 2002-2003, 58.7 years in the study by Lee et al.22 performed in 2002-2003, and 61 years in the study by Kim et al.23 performed in 2003. From these results, it appears that the average age of patients with NTM has been increasing since the late 1990s. Further research is warranted to investigate this phenomenon. In this study, NTM species were more commonly isolated from men than from women; however, NTM was not strongly associated with gender, but rather depended more on region and timing. The average age of patients with NTM has been increasing since the late 1990s. The variation in rates reported by different hospitals may be due to variations in patient group characteristics, research periods, the specimen collection and detection methods used, and NTM detection thresholds. The NTM species in the 232 samples in this study were as follows: M. intracellulare (119 samples, 51.3%), M. avium (34, 14.7%), and M. kansasii (18, 7.8%). In a study performed in Seoul17, MAC was found in 138 of the 328 samples (42.1%), while other identified species included M. fortuitum (64, 15.2%), M. abscessus (37, 11.3%), and M. gordonae (33, 10.1%). However, in a study conducted in the Masan20 area, MAC was found in 55 of 100 samples (55%), while other species included M. abscessus (25, 25%), M. fortuitum (9, 9%), and M. chelonae (8, 8%). In a study from Ulsan5, 22.7% of isolates from a total of 384 samples were identified as MAC, while 15.9% were M. kansasii, 11.5% were M. gordonae, and 8.9% were M. fortuitum. In a study conducted in Hong Kong24, 19% of detected species were M. gordonae, 15% were M. terrae, 12% were M. fortuitum, and 5% were M. chelonae. A Danish survey25 found that 55.3% of NTM isolates were M. gordonae, 19.3% were MAC, 4.8% were M. fortuitum, and 3.9% were M. abscessus. Finally, a US study26 reported rates of 80.1% for MAC, 12.1% for M. chelonae/abscessus, 5.6% for M. fortuitum, and 5.5% for M. kansasii. M. gordonae is often regarded as a contaminant7, although infections due to M. gordonae have been reported in some patients, such as those in an immunocompromised state27,28. Our results are quite different from those of studies performed in other countries, which further suggests that NTM disease depends on the characteristics of regional populations29. In this study, NTM were found in 232 samples (7.17% positive rate in cultured specimens). The positive rate in Korea30,31 in the 1960s was <1%. In 1970, Kim et al.30 identified NTM species in sputum at a rate of 2.7%. More recently, NTM isolation rates in cultured specimens have been found to be approximately 10-30%, as represented by those from Seoul Asan Hospital32 (21.9%) in 2002, Seoul National University (SNU) Hospital9 (21.5%) in 2006, Fatima Hospital33 (7.9%) in 2009, and Gil Hospital34 (19.4%) in 2012. The variation in rates reported by different hospitals may be due to variations in patient group characteristics, research periods, specimen collection and detection methods used, and NTM detection thresholds. Along with increases in the proportion of NTM isolates reported from referred specimens, the NTM ratio of respiratory AFB culture-positive specimens also increased between 2005 and 2011. Overall, an upward trend in NTM incidence was found during the study period. Given these clinical challenges, further knowledge of the epidemiology of NTM in Korea is needed. Such knowledge will be beneficial in the treatment of NTM disease and the development of clinical science.
  19 in total

1.  Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene.

Authors:  H Lee; H J Park; S N Cho; G H Bai; S J Kim
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

3.  Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea.

Authors:  K Jeon; W J Koh; O J Kwon; G Y Suh; M P Chung; H Kim; N Y Lee; Y K Park; G H Bai
Journal:  Int J Tuberc Lung Dis       Date:  2005-09       Impact factor: 2.373

4.  Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea.

Authors:  Y S Park; C-H Lee; S-M Lee; S-C Yang; C-G Yoo; Y W Kim; S K Han; Y-S Shim; J-J Yim
Journal:  Int J Tuberc Lung Dis       Date:  2010-08       Impact factor: 2.373

5.  Mycobacterium gordonae: a new pathogen?

Authors:  J G Douglas; M A Calder; Y F Choo-Kang; A G Leitch
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

Review 6.  Infections due to non-tuberculous mycobacteria (NTM).

Authors:  V M Katoch
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

7.  Mycobacterium kansasii pulmonary diseases in Korea.

Authors:  Jae-Joon Yim; Young-Kil Park; Woo Jin Lew; Gill-Han Bai; Sung Koo Han; Young-Soo Shim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 8.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 9.  Nontuberculous mycobacterial pulmonary disease.

Authors:  K N Olivier
Journal:  Curr Opin Pulm Med       Date:  1998-05       Impact factor: 3.155

Review 10.  Nontuberculous mycobacteria in respiratory tract infections, eastern Asia.

Authors:  Sami Simons; Jakko van Ingen; Po-Ren Hsueh; Nguyen Van Hung; P N Richard Dekhuijzen; Martin J Boeree; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

View more
  12 in total

1.  Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Authors:  Won-Jung Koh; Byeong-Ho Jeong; Kyeongman Jeon; Hye Yun Park; Su-Young Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

2.  Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomy.

Authors:  C H Kim; K H Im; S S Yoo; S Y Lee; S I Cha; H Y Jung; J Y Park; W Yu; J Lee
Journal:  Infection       Date:  2014-05-10       Impact factor: 3.553

3.  Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.

Authors:  Hyung Koo Kang; Hye Yun Park; Dohun Kim; Byeong-Ho Jeong; Kyeongman Jeon; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2015-02-19       Impact factor: 3.090

4.  Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000-2012.

Authors:  Jung-Yien Chien; Chih-Cheng Lai; Wang-Huei Sheng; Chong-Jen Yu; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

5.  The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China.

Authors:  Yan Shao; Cheng Chen; Honghuan Song; Guoli Li; Qiao Liu; Yan Li; Limei Zhu; Leonardo Martinez; Wei Lu
Journal:  PLoS Negl Trop Dis       Date:  2015-03-16

6.  Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis.

Authors:  Faming Jiang; Weiwei Huang; Ye Wang; Panwen Tian; Xuerong Chen; Zongan Liang
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

7.  Increasing Burden of Nontuberculous Mycobacteria in Korea.

Authors:  Seung Jung Kee; Soon Pal Suh
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

Review 8.  Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.

Authors:  Yong-Soo Kwon; Won-Jung Koh
Journal:  J Korean Med Sci       Date:  2016-03-22       Impact factor: 2.153

9.  Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014.

Authors:  Laura Rindi; Carlo Garzelli
Journal:  BMC Infect Dis       Date:  2016-02-01       Impact factor: 3.090

10.  Isolation of Mycobacterium tuberculosis from livestock workers and implications for zooanthroponotic transmission in Ibadan, South-western Nigeria.

Authors:  S Cadmus; V Akinseye; A Adegbulu; N Ovwighose; M Ayoola; J Ogugua; H Adesokan; E Cadmus
Journal:  J Prev Med Hyg       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.